scholarly journals Docetaxel and carboplatin is an active regimen in advancednon-small-cell lung cancer: a phase II study in Caucasian and Asian patients

2003 ◽  
Vol 14 (3) ◽  
pp. 449-454 ◽  
Author(s):  
M.J. Millward ◽  
M.J. Boyer ◽  
M. Lehnert ◽  
S. Clarke ◽  
D. Rischin ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Asian Patients

Phase II study of crizotinib in east Asian patients (pts) with ROS1-positive advanced non-small cell lung cancer (NSCLC).

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 9022-9022 ◽  
Author(s):  
Koichi Goto ◽  
James Chih-Hsin Yang ◽  
Dong-Wan Kim ◽  
Shun Lu ◽  
Takashi Seto ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
East Asian ◽  
Small Cell ◽  
Small Cell Lung ◽  
Asian Patients ◽  
East Asian Patients

scholarly journals Phase II study of Crizotinib in East Asian patients (pts) with ROS1+ advanced non-small cell lung cancer (NSCLC)

2017 ◽  
Vol 28 ◽  
pp. ix91
Author(s):  
Koichi Goto ◽  
James CHYang ◽  
Dong-Wan Kim ◽  
Shun Lu ◽  
Jianying Zhou ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
East Asian ◽  
Small Cell ◽  
Small Cell Lung ◽  
Asian Patients ◽  
East Asian Patients

A phase II study with gemcitabine and split-dose cisplatin in patients with advanced non-small cell lung cancer

Lung Cancer ◽  
2006 ◽  
Vol 54 (1) ◽  
pp. 57-62 ◽  
Author(s):  
Jung Han Kim ◽  
Dong Hun Lee ◽  
Hyun Chun Shin ◽  
Jung Hye Kwon ◽  
Joo Young Jung ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Split Dose
Sign in / Sign up

Export Citation Format

Share Document